Medicare Enrolled

Dr. Chirag Shah

Gynecologic Oncology Physician · Seattle, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1101 MADISON ST, Seattle, WA 98104
2069651700
In practice since 2006 (19 years)
NPI: 1235248360 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Chirag Shah is a gynecologic oncology physician in Seattle, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 299 Medicare services across 242 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shah received a total of $784,617 from 20 pharmaceutical and/or device companies across 751 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 22% volume in WA $784,617 industry payments

Medicare Practice Summary

Medicare Utilization ↗
299
Medicare services
Top 22% in WA for gynecologic oncology physician
242
Unique beneficiaries
$190
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
New patient office visit, complex (60-74 min) 55 $182 $595
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
54 $111 $315
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $100 $312
Laparoscopic hysterectomy with salpingo-oophorectomy, 250g or less
Surgical removal of the uterus, fallopian tubes, and/or ovaries through small abdominal incisions using a camera-guided instrument. The procedure is specified for cases where the removed tissue weighs 250 grams or less.
32 $719 $2,665
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
31 $78 $222
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
28 $73 $221
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
24 $150 $438
Intraoperative lymph node imaging
Imaging performed during surgery to visualize lymph nodes.
16 $169 $588
Endoscopic biopsy and removal of abdominal lymph nodes
A procedure to examine and remove lymph nodes in the abdominal cavity using an endoscope. The endoscope allows the provider to access the area through a small incision.
12 $201 $1,461
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$784,617
Total received (2018-2024)
Avg $112,088/year across 7 years
Top 4% in WA for gynecologic oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
751
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$721,052 (91.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$61,435 (7.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,130 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$173,604
2023
$152,700
2022
$94,335
2021
$37,652
2020
$33,917
2019
$145,172
2018
$147,237

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$47,010
Genmab U.S., Inc.
$42,886
GlaxoSmithKline, LLC.
$42,780
INTUITIVE SURGICAL, INC.
$22,660
PFIZER INC.
$17,803
Myriad Genetic Laboratories, Inc.
$149
ImmunoGen, Inc.
$119
Johnson & Johnson Surgical Vision, Inc.
$116
AstraZeneca Pharmaceuticals LP
$83
Top 3 companies account for 76.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$187,782
TESARO, Inc.
$160,959
Clovis Oncology, Inc.
$94,880
Genmab U.S., Inc.
$84,222
ABBVIE INC.
$47,010
Seagen Inc.
$46,238
ImmunoGen, Inc.
$33,557
AbbVie, Inc.
$30,873
INTUITIVE SURGICAL, INC.
$22,660
AstraZeneca Pharmaceuticals LP
$20,307
PFIZER INC.
$17,803
Intuitive Surgical, Inc.
$15,483
AbbVie Inc.
$14,252
Genentech USA, Inc.
$6,743
Davol Inc.
$695
Stryker Corporation
$452
Myriad Genetic Laboratories, Inc.
$278
Johnson & Johnson Surgical Vision, Inc.
$204
Abbott Laboratories
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Top 3 companies account for 56.5% of all-time payments
Associated products mentioned in payments ›
Avastin · CARDIOMEMS · DA VINCI SP · DAVINCI XI · Da Vinci Surgical System · ELAHERE · Elahere · IMFINZI · JEMPERLI · LYNPARZA · MYCHOICE CDX · ORIAHNN · ORILISSA · Orilissa · PRECISETUMOR · Progel · Rubraca · SPY-PHI SYSTEM · STIOLTO · STIOLTO RESPIMAT · TECNIS IOL · TIVDAK · Tecnis IOL · Tivdak · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gynecologic oncology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for gynecologic oncology physician in WA.

Looking for a gynecologic oncology physician in Seattle?
Compare gynecologic oncology physicians in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse gynecologic oncology physicians nearby

Geographic Context

Gynecologic oncology physicians within 10 mi
18
Per 100K population
0.8
County median income
$122,148
Nearest hospital
HARBORVIEW MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 22% in WA), with speaking/promotional industry engagement in the top 4% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shah experienced with new patient office visit, complex (60-74 min)?
Based on Medicare claims data, Dr. Shah performed 55 new patient office visit, complex (60-74 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $784,617 from 20 companies across 751 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other gynecologic oncology physicians in Seattle?
Dr. Shah's average Medicare payment per service is $190. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →